Michael Crowley is VP at BIO-RAD LABORATORIES, INC. (BIO). They have made 23 open-market trades across 1 company since 2015, most recently 2024-09-03.
CIK 0001629381
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 23 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BIO | 7,358 | $2.6M |
Shares reported on the most recent Form 4, priced at the 2024-09-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BIO | SELL | 2024-06-13 | 2024-06-14 | $281.91 | $104K | -5.2% | +5.3% | +12.2% |
| BIO | SELL | 2024-02-27 | 2024-02-28 | $336.00 | $1.0M | +3.8% | +2.2% | -13.7% |
| BIO | SELL | 2023-11-28 | 2023-11-28 | $305.10 | $196K | -0.3% | +6.4% | +10.8% |
| BIO | SELL | 2023-06-15 | 2023-06-16 | $379.39 | $190K | +3.5% | +7.0% | +3.0% |
| BIO | SELL | 2021-08-09 | 2021-08-10 | $754.93 | $2.3M | +2.5% | +6.5% | -3.8% |
| BIO | SELL | 2020-12-15 | 2020-12-17 | $580.67 | $217K | -1.9% | +3.9% | -3.3% |
| BIO | SELL | 2020-06-01 | 2020-06-02 | $485.40 | $728K | -9.0% | -7.1% | +3.1% |
| BIO | SELL | 2019-09-04 | 2019-09-05 | $333.08 | $725K | -0.0% | +0.3% | +10.0% |
| BIO | SELL | 2019-08-14 | 2019-08-14 | $320.00 | $104K | +4.9% | +4.7% | +10.4% |
| BIO | SELL | 2018-12-14 | 2018-12-14 | $248.03 | $194K | -7.1% | -4.5% | +26.0% |
| BIO | SELL | 2018-06-13 | 2018-06-14 | $303.42 | $106K | -4.0% | -0.6% | +1.1% |
| BIO | SELL | 2017-12-04 | 2017-12-04 | $258.39 | $258K | -3.0% | -2.7% | +1.0% |
| BIO | SELL | 2017-08-11 | 2017-08-11 | $215.91 | $151K | -0.6% | -0.1% | +22.0% |
| BIO | SELL | 2017-03-07 | 2017-03-08 | $196.13 | $59K | +0.2% | +3.6% | +15.8% |
| BIO | SELL | 2016-11-07 | 2016-11-08 | $165.62 | $15K | -1.4% | +3.2% | +10.4% |
| BIO | SELL | 2016-09-13 | 2016-09-14 | $158.09 | $20K | +2.1% | +2.9% | +15.4% |
| BIO | SELL | 2016-09-12 | 2016-09-13 | $155.02 | $162K | +2.8% | +2.6% | +14.3% |
| BIO | SELL | 2016-08-18 | 2016-08-18 | $153.00 | $102K | -2.0% | +4.2% | +12.3% |
| BIO | SELL | 2015-11-13 | 2015-11-16 | $136.16 | $75K | -8.1% | -0.7% | -7.1% |
| BIO | SELL | 2015-09-14 | 2015-09-15 | $139.11 | $38K | -8.1% | -0.7% | -0.7% |
| BIO | SELL | 2015-09-11 | 2015-09-14 | $137.50 | $21K | -8.1% | -0.7% | -0.7% |
| BIO | SELL | 2015-09-09 | 2015-09-10 | $139.01 | $13K | -8.1% | -0.7% | -0.7% |
| BIO | SELL | 2015-03-10 | 2015-03-12 | $134.05 | $27K | -8.1% | -0.7% | -0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.